Abstract. It has been reported that clarithromycin (CAM) augments the anti-tumor activity of thalidomide against multiple myeloma (MM) cells, while the mechanism remains unclear. A myeloma cell line or primary myeloma cells were treated with CAM. Autophagy was analyzed by morphological changes, LC3 expression and lysotracker staining. CAM induced vacuoles in the cytoplasm of MM cells which resembled autolysosomes. The manifestation of the CAMinduced vacuoles was blocked by treatment with PI3-kinase inhibitor. CAM induced an accumulation of LC3-II without affecting the mTOR or AKT pathways, eventually leading to cell death. CAM may halt the autophagy process after fusion of autophagosomes with lysosomes. This phenomenon may explain how CAM, combined with thalidomide, augments the cytotoxic effects of the latter on MM cells and suggests that modification of autophagy might represent a new approach for therapy of MM.
Introduction
Certain macrolide antibiotics are known to exert effects other than anti-bacterial activity, such as growth inhibition of certain cancer cells. Prolonged survival of lung cancer patients treated with macrolides, and experiments showing anti-tumor activity of CAM have been reported (1) (2) (3) (4) (5) . In experimental settings, various effects of macrolides have been reported, e.g., anti-angiogenesis (6) and direct antitumor activity (7) . Clarithromycin (CAM) is known to exert a potent anti-tumor effect on multiple myeloma cells, when combined with thalidomide or dexamethasone (8) , despite there being some controversy at a setting of mono-therapy (9) . Of note, high efficacy to myeloma of chemotherapeutic regimen combining CAM with lenalidomide, a derivative of thalidomide, has recently been reported (10) .
In an attempt to clarify the mechanisms regulating the anti-tumor activity of CAM, we analyzed its direct effect on myeloma cells in vitro. We showed significant induction of vacuoles in human myeloma cell lines and primary myeloma cells by the treatment with CAM, which are related to morphological features of autophagy. Detailed analysis revealed that inhibition of autophagy process at late stage by CAM may contribute augmentation of anti-myeloma effect. We believe that this report is the first one showing a contribution of CAM to autophagy. Moreover, this finding may lead to a novel therapeutic approach by manipulating autophagy system, which has been proposed, but not yet clinically achieved (11) .
Materials and methods
Cells and cell culture. The myeloma cell line 12PE (12) , and primary myeloma cells purified by CD138-conjugated immuno-magnetic beads (Miltenvi Biotec, Auburn, CA, USA) were utilized. Clarithromycin (CAM) was obtained from Taisho-Toyama Pharmaceuticals (Tokyo, Japan) and dissolved in DMSO at a concentration of 10 mg/ml as a stock solution. Cells were cultured in RPMI-1640 medium supplemented with 10% fetal calf serum (Sigma, St. Louis, MO, USA) at 37˚C under humidified conditions. Analysis of autophagy. Morphology was analyzed either by May-Giemsa staining or electron microscopy. Lysosomes were stained with LysoTracker (Invitrogen, Carlsbad, CA, USA) and analyzed using fluorescent microscopy. Antibodies to LC3 were a kind gift of Dr T. Yoshimori (Department of Cellular Regulation, Research Institute for Microbial Diseases, Osaka University). Antibodies to phospho-AKT, AKT and p-70S6K1 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Western blotting was performed by utilizing a Pre-cast Gel kit (Invitrogen), and membranes were visualized by ECL Plus detection kit (GE Healthcare Bio-Sciences, Uppsala, Sweden). 3-methyladenine, LY294002 and Bafilomycin A (BAF) were purchased from Sigma. Microscopic analysis for LysoTracker staining, a dye that stains acidic lysosomes, was performed with confocal laser scanning microscopy (Olympus, Tokyo, Japan).
Electron microscopy. Cell pellets were fixed with 1.0% glutaraldehyde for 60 min and postfixed with 1.0% osmium tetroxide for 30 min at 4˚C. After dehydration in a graded ethanol series, the cells were embedded in epoxy resin. Ultrathin sections stained with uranyl acetate and lead citrate were observed using an H-7500 electron microscope (Tokyo, Japan).
Flow cytometry. Cells were stained with the Annexin V/PI staining kit (Medical and Biological Laboratory, Nagoya, Japan). Cells were then analyzed by Epics V flow cytometer (Coulter, Miami, FL, USA).
Results

Induction of vacuoles by CAM.
The myeloma cell line 12PE was incubated with CAM at various concentrations for 18 h. Vacuolization was morphologically observed after treatment with CAM at a concentration of 50 μg/ml, and increased in a time-dependent manner with maximum vacuolization at 12.5 μg/ml which is potentially achievable concentration within cytoplasm (Fig. 1A) . Quantification of vacuoles revealed that CAM increased vacuolization in a dose-dependent manner (Fig. 1B) . Electron microscopy revealed that the small vacuoles represented vacuoles that contained degenerated organelles (Fig. 2B ) and larger vacuoles containing no organelles ( Fig. 2C ) which are considered to be autophagosomes and autolysosomes, respectively. Primary purified myeloma cells cultured with CAM at a concentration of 10 μg/ml for 18 h showed similar vacuole formation to that found in cell lines (Fig. 3) .
Co-localization of vacuoles with lysosomes.
Electron microscopy suggested that small vacuoles are autophagosomes, therefore, we hypothesized that large vacuoles observed by light microscopy may have been autolysosomes. To confirm this hypothesis, 12PE cells were treated with CAM and stained with LysoTracker, a dye that stains acidic lysosomes. As shown in Fig. 4 , large vacuoles were stained red with LysoTracker, which clearly indicated that the vacuoles were acidic lysosomes. When cells were treated with CAM at increasing doses, vacuoles stained with LysoTracker accumulated in a dose-dependent manner (Fig. 5) . This finding was also confirmed in primary purified myeloma cells (Fig. 6) .
CAM induces accumulation of LC3-II.
Taking these results together, it is suggested that CAM-induced vacuoles are autophagy-related vacuoles. To further examine this possibility, we analyzed processing of LC3-I to LC3-II, a hallmark of autophagy. We found that more accumulation of LC3-II by CAM as concentration of CAM increased (Fig. 7A) . These results indicate either induction of autophagy or inhibition of autophagy at late stage by CAM. Subsequently, phosphorylated and total Akt were analyzed, since autophagy is initiated by dephosphorylation of Akt (13) . However, phosphorylated Akt was not inhibited by CAM (Fig. 7B) , suggesting that CAM may not induce autophagy through dephospholyration of AKT. 
Inhibition of vacuolization by 3-methyladenine.
We further examined p70S6K1 since it locates downstream of mTOR, which is known to inhibit autophagy (14, 15) . There was no reduction of phospholyrated p70S6K by CAM (Fig. 7B) while rapamycin, an inhibitor of mTOR, markedly decreased phospho-p70S6K. These results suggest that CAM is not involved in regular autophagy initiation process mediated by mTOR inhibition.
We further treated cells with autophagy inhibitor 3-methyladenine (3MA), an inhibitor of autophagy-initiation, in combination with CAM. Interestingly, vacuole formation by CAM was clearly inhibited by 3MA, as shown by morphological analysis (Fig. 8A ) and LysoTracker staining (Fig. 8B) , suggesting that CAM-induced vacuole formation locates downstream of autophagy initiation.
Induction of cytotoxicity by CAM.
Since the combination of CAM and thalidomide is reported to be effective for myeloma (8,10), we considered that CAM alone might affect cell viability. To analyze this possibility, 12PE cells were treated with CAM and analyzed by Annexin V/PI staining. As shown in Fig. 9 , CAM induced necrotic cell death or late apoptosis, which is shown by double positivity for Annexin V and PI. Since CAM induced vacuolization of cytoplasm, which is distinct from fragmentation of nucleus, and no significant induction of caspase 3 by CAM (data not shown), CAM induced necrotic cell death rather than apoptosis.
Discussion
Autophagy is a phenomenon that starts with autophagosome formation and leads to fusion of autophagosomes with lysosomes (16) . It is recognized that the initiation of autophagy is induced by nutrient starvation. Although a direct and simple method for identifying autophagy has not been established, specific morphology under the electron microscope and processing of LC3-I to LC3-II are well recognized as features of autophagy (17) . As these processes are controlled by 3MA (18) , inhibition of vacuoles by 3MA also confirms that vacuoles are related to autophagy.
As we found induction of small vacuolization following treatment with CAM that led to large vacuole formation we investigated the possible relation of autophagy with CAM, and found that CAM indeed induced autophagic vacuoles, which was proven by morphological examination with electron microscopy and detection of LC3-II. Induction of autophagic vacuoles by CAM was further confirmed by treating cells with 3MA. It is understood that autophagy is accompanied by inhibition of the phospho-AKT (13) and inhibits phosphorylation of mTOR, as rapamycin induces autophagy by inhibiting mTOR (19) . However, our results showed that CAM did not inhibit phosphorylation of AKT nor p70S6K, indicating that CAM does not likely induce autophagy.
Surprisingly, there was accumulation of large vacuoles in a time-dependent manner in the presence of CAM, even 18 h after its addition. This finding might be explained by potent and continuous inhibition of autophagy by CAM at late stage of autophagy process. As we found marked accumulation of LC3-II by the treatment with bafilomycin (data not shown), CAM may exert similar effect although the point of inhibition may be different (Fig. 10) . Based on the fact that both bafilomycin and CAM belong to macrolides, inhibition of autophagy process by CAM may not be an unexpected phenomenon. It is hypothesized that accumulation of autolysosomes is needed for CAM to encapsulate foreign microorganisms into autophagosomes, since autophagy is not only an energy-recycling process, but also a self-defense process, as shown with Streptococcus (20) . This hypothesis may fit our findings, because CAM is an active agent against intracellular micro-orgasms such as Mycobacterium. Despite the fact that we found accumulation of autophagic vacuoles by CAM in tumor cells, a similar phenomenon may exist in normal immune cells, such as macrophages. Further evaluation of the hypothesis requires an experimental system that utilizes microorganisms and macrophages.
We found a cytotoxic effect of CAM in myeloma cells. This effect is distinct from apoptosis in terms of characteristics in morphology, flow cytometry analysis and activation of caspases. We consider that CAM-induced cell death might be from inhibition of autophagy. It is hypothesized that autophagy might be constitutively active in myeloma cells because of their hypoxic circumstances in the bone marrow where myeloma cells grow in vivo as Azad et al reported (21) . Therefore, autophagy should play an important role in myeloma cells under various stresses (22) . CAM may disrupt this rescue pathway thus resulting in cell death in vivo as we found vacuole formations in primary MM cells. This concept has been reported by Ito et al, showing inhibition of autophagy results various anti-tumor effects in malignant tumors (23, 24) .
We found that CAM induced various phenomenon at concentration from 6 to 50 μg/ml. Pharmacokinetic analysis showed concentration of CAM in serum is approximately 1 μg/ml (25) while it concentrates >10 times in cytoplasm (26) , indicating that our in vitro experiments were appropriate.
We believe that this report is the first showing induction of autophagy by CAM, which is a well-known and worldwide utilized orally taken antibiotic. Despite our findings only referring to myeloma cells, a similar phenomenon may be found in various tumor cells, which show a survival benefit following treatment with CAM, such as lung cancer cells (1) (2) (3) (4) (5) 27, 28) . In this context, unveiling of mechanisms regulating autophagy by CAM should be important not only for understanding the biology of cancer cells but also extending survival of cancer patients.
